Insulin Pens for Diabetes: A Complete Scientific Guide | Everyday Health
How the new generation of weight-loss drugs work
RACGP - Semaglutide supplies return to Australia ahead of schedule
New GLP-1 weight loss drugs are about to ship to more American homes
Tirzepatide (Mounjaro): A Q&A With the ADA's Dr. Robert Gabbay | Everyday Health
The Dos and Don'ts of Insulin Injections - Type 2 Diabetes Center - Everyday Health
The Science Behind Controversial New Weight Loss Drugs Like Ozempic
Invention could help diabetics with safer, surer insulin injections
New diabetes treatment could eliminate need for insulin injections | Medical research | The Guardian
Introducing Ozempic - Diabetes Australia
Another Weight-Loss Trial Win for Weekly GLP-1 Drug | MedPage Today
New diabetes drugs do not tackle root causes of obesity, experts warn | Obesity | The Guardian
Xeris Pharmaceuticals erhält von der Europäischen Kommission die Zulassung für die Ogluo™-Injektion (Glucagon) zur Behandlung von schwerer Hypoglykämie bei Erwachsenen, Jugendlichen und Kindern ab 2 Jahren mit Diabetes mellitus | Business Wire
Lyumjev (insulin lispro-aabc) for Type 1 and Type 2 Diabetes
New insulin pill could end daily injections for diabetes patients | Science & Tech News | Sky News
Diabetes Patients Also Struggle to Access GLP-1 Agonists | MedPage Today
Lilly's new diabetes drug doubled sales expectations. It may also be used to treat obesity - MarketWatch
Type 2 diabetes: New treatment for diabetes is launched in UK | Express.co.uk
FDA Approves Higher Doses of Trulicity To Help People with Type 2 Diabetes
People with diabetes struggle to find Ozempic as it soars in popularity as a weight loss aid
Type 2 Diabetes Drug Tirzepatide (Mounjaro) Aids Weight Loss in People With Obesity: Study | Everyday Health
Type 1 diabetes treatment finds new target
World-first diabetes drug represents 'a seismic shift' in treatment | The Independent
